Related Experiment Video
Updated: Jun 4, 2026

Visualizing Mitophagy with Fluorescent Dyes for Mitochondria and Lysosome
Published on: November 30, 2022
Therapy mediated by mitophagy abrogates tumor progression
Ricardo Gargini1, Vega García-Escudero, Marta Izquierdo
1Department of Molecular Biology/Centro de Biología Molecular Severo Ochoa, UAM/CSIC, Universidad Autónoma de Madrid; Madrid, Spain.
Abstract:
Autophagy is mainly a cellular recycling process that promotes survival, but it can also cause cell death if cell injury persists. The role of mitophagy in tumorigenesis remains uncertain. Other cell death types, such as apoptosis or necrosis, are often altered during tumor development and therefore are not ideal targets to generate efficient antitumor therapies. We have used the system linamarase/linamarin/glucose oxidase (lis/lin/GO) to eliminate tumor cells. This therapeutic strategy is based on the combination of cyanide and oxidative stress to abrogate tumor growth. After severe mitochondrial insult by lis/lin/GO, the electron transport chain is blocked and hydrogen peroxide production increased. This triggers a degradative phase of these damaged organelles inducing mitophagy that finally leads to cell death. This death process depends on the vacuole generation, BNIp3 and the formation of autolysosomes. Importantly, evasion of apoptosis is known to result in resistance to anti-cancer therapies but this inhibition also augments sensitivity to autophagy, which could be used to promote tumor regression. We explored the potential of this powerful mitophagy-inducing system in vitro and in vivo to eradicate human malignant tumors.
Insights
This study introduces a novel therapeutic system combining cyanide and oxidative stress to induce mitophagy, a cellular recycling process, for targeted tumor cell elimination. This approach offers a promising strategy for cancer therapy, especially when apoptosis pathways are resistant.
Area of Science:
- Cell Biology
- Oncology
- Biochemistry
Background:
- Autophagy, a cellular recycling process, primarily promotes survival but can induce cell death under persistent injury.
- The specific role of mitophagy in tumorigenesis is not yet fully understood.
- Conventional cell death pathways like apoptosis are often dysregulated in tumors, limiting their therapeutic potential.
Purpose of the Study:
- To investigate the potential of a novel therapeutic system (linamarase/linamarin/glucose oxidase) to eliminate tumor cells.
- To explore the induction of mitophagy as a mechanism for cancer cell death.
- To evaluate the efficacy of this mitophagy-inducing system in vitro and in vivo for eradicating human malignant tumors.
Main Methods:
- Utilized the linamarase/linamarin/glucose oxidase (lis/lin/GO) system to induce severe mitochondrial insult in tumor cells.
- Analyzed the blockage of the electron transport chain and increased hydrogen peroxide production.
- Investigated the role of vacuole generation, BNip3, and autolysosome formation in the cell death process.
Main Results:
- The lis/lin/GO system effectively triggered mitophagy, leading to tumor cell death.
- The observed cell death pathway involved cyanide and oxidative stress, culminating in the degradation of damaged organelles.
- Tumor cells resistant to apoptosis showed increased sensitivity to this autophagy-inducing therapy.
Conclusions:
- The lis/lin/GO system represents a potent strategy for inducing mitophagy-mediated tumor cell death.
- This approach leverages the interplay between apoptosis evasion and autophagy sensitivity for enhanced anti-cancer therapy.
- The findings suggest a promising new avenue for developing effective treatments against human malignant tumors.
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Abnormal Proliferation
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

